Mandate

Vinge advises BHG Group in connection with the acquisition of Hafa Bathroom Group

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 94% of the shares in Hafa Bathroom Group.

Hafa Bathroom Group is Sweden’s largest privately-owned bathroom company with a market leading online platform. The company primarily sells products under the three trademarks of Hafa, NORO and Westerbergs and conducts operations in all of the Nordic countries and in the Baltic Region. During 2020, the turnover amounted to approximately MSEK 200 with good profitability.

BHG Group is the largest online actor within consumer trading in the Nordic Region and the largest actor in Europe within home improvement, which includes both Do It Yourself and Home Furnishing. BHG Group’s e-trading operations employ approximately 2,000 people and include more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

The transaction is subject to customary approvals by public authorities.

Vinge’s team consisted of Kristian Ford together with, among others, Niklas Törnell, Lena Westberg, Julia Ahlqvist, Karin Gynnerstedt, Johanne Örnfeldt Svensson, Philip Åberg and Pär Remnelid (competition law).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025